Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDrax Regulatory News (DRX)

Share Price Information for Drax (DRX)

Share Price is delayed by 15 minutes
Get Live Data
773.00    -11.50 (-1.47%)
Bid:
777.50
Ask:
778.00
Spread: 0.50 (0.064%)
Market Cap: £2.60b
DRX Live PriceLast checked at - London Stock Exchange

Intraday Drax Share Chart

Share Buyback Programme

7 Aug 2024 07:00

RNS Number : 4506Z
Drax Group PLC
07 August 2024
 

7 August 2024

 

DRAX GROUP PLC

(Symbol: DRX)

 

Share Buyback Programme

 

Drax Group plc (the "Company") today announces that, in connection with the up to £300 million share buyback programme announced on 26 July 2024 (the "Programme"), it is commencing the first tranche of a share buyback programme to purchase ordinary shares of 11 16/29 pence each in the Company up to a maximum consideration of £75 million (the "First Tranche"). The purpose of the First Tranche is to reduce the Company's share capital. The ordinary shares purchased by the Company will be held in treasury pending cancellation or re-issue.

 

Ordinary share purchases as part of the First Tranche of the Programme will take place in open market transactions and may be made from time to time depending on market conditions, share price and trading volumes. The maximum number of shares that may be repurchased by the Company under the First Tranche of the Programme is 38,468,257, being the number of shares the Company is authorised to purchase pursuant to the authority granted by shareholders at the AGM on 25 April 2024, which authority would be expected to be renewed at the AGM to be held in 2025.

 

The Company has entered into a non-discretionary agreement with RBC Europe Limited ("RBC") pursuant to which it has issued irrevocable instructions to RBC to conduct the First Tranche of the Programme. RBC will carry out the First Tranche of the Programme through the acquisition of ordinary shares in the Company, within certain pre-defined parameters, for subsequent repurchase by the Company. Any purchase of ordinary shares in the Company will be conducted within the parameters prescribed by the Market Abuse Regulation 596/2014 and the Commission Delegated Regulation (EU) 2016/1052 (also as in force in the UK, from time to time, including, where relevant, pursuant to the UK's European Union (Withdrawal) Act 2018 and the Market Abuse (Amendment) (EU Exit) Regulations 2019) as well as applicable laws and the regulations of the UK Financial Conduct Authority (including Chapter 9 of the UK Listing Rules).

 

The Company will make further announcements in due course following the buyback of shares. Note there is no guarantee that the Programme will be implemented in full.

 

Enquiries:

Drax Investor Relations: Mark Strafford

+44 (0) 7730 763 949

Chris Simpson

+44 (0) 7923 257 815

 

Media:

Drax External Communications: Andy Low

+44 (0) 7841 068415 

 

RBC Europe Limited:

James Agnew / Jack Wood

+44 (0) 20 7404 5959

 

Website: www.drax.com

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFZGGRLVMGDZM
Date   Source Headline
5th Jun 202610:21 amRNSHolding(s) in Company
1st Jun 202611:02 amRNSIssue of Shares
1st Jun 202610:28 amRNSTotal Voting Rights
1st Jun 20267:47 amRNSDisclosure Table
1st Jun 20267:00 amRNSOffer for Bluefield Solar Income Fund Limited
29th May 20267:00 amRNSCommissioning of First OCGT Plant
27th May 20267:00 amRNSChief Financial Officer
26th May 20268:45 amRNSApplication for block admission to trading
8th May 20269:00 amRNSDirector/PDMR Shareholding
1st May 202610:15 amRNSTotal Voting Rights and Issue of Shares
30th Apr 202612:53 pmRNSResult of AGM
30th Apr 20267:00 amRNSTrading Update
15th Apr 20268:45 amRNSApplication for block admission to trading
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 202612:46 pmRNSTotal Voting Rights
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 202612:09 pmRNSIssue of Shares
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20269:48 amRNSNotice of AGM and Annual Report and Accounts
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 202610:35 amRNSHolding(s) in Company
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20264:43 pmRNSDirector/PDMR Shareholding
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSCapacity Market Agreements
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSAppointment of Interim CFO
5th Mar 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.